Walter Kraft, MD
Professor
Director, Division of Clinical Pharmacology
Director, Clinical Research Unit
Director, Office of Human Research
Contact
132 South 10th Street
1170 Main Building
Philadelphia, PA 19107
215-955-9077
215-955-5681 fax
Featured Links
Walter Kraft, MD
Professor
Director, Division of Clinical Pharmacology
Director, Clinical Research Unit
Director, Office of Human Research
Education
Medical School
University of Pittsburgh
Residency
Thomas Jefferson University Hospital
Fellowship
Thomas Jefferson University Hospital
Publications
- Polygenic risk scores and the need for pharmacotherapy in neonatal abstinence syndrome
- Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial
- Platelet protease activated receptor 4 (PAR 4) receptor genotype is associated with an increased risk of preterm birth
- Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
- Clinical Pharmacology and the Best Use of Public Research Investment
Board Certification
Internal Medicine
Clinical Pharmacology
Hospital Appointment
Thomas Jefferson University Hospital
Research Interests
- Phase one clinical trials
- Treatment of neonatal abstinence syndrome
- Clinical Pharmacology
Clinical Interests
- Anticoagulation
- Hospital-based vascular medicine consultation
Industrial Relevance
Dr. Kraft has expertise in the clinical, regulatory, and managerial aspects of Phase 1 drug development.
Biography
Dr. Kraft is an internist and a clinical pharmacologist. He is the director of the Thomas Jefferson University Clinical Research Unit. The CRU, located within the Thomas Jefferson University Hospital, specializes in Phase 1 trials in federally funded and industry sponsored investigations. Populations have included both heathy volunteers, as well as adult and pediatric patients with cancer, Hepatitis C, end stage renal disease, epilepsy, hemophilia, and migraine. He has an interest in the development of novel therapeutics in the neonatal abstinence syndrome (NAS). He is co-PI on the NIGMS funded fellowship program in Clinical Pharmacology at Jefferson. He is director of the Jefferson Office of Human Research, which oversees all human subjects’ protection for the Jefferson enterprise. He had held national leadership in a number of professional organizations including treasurer of American Society for Clinical Pharmacology and Therapeutics, and board membership on American Board of Clinical Pharmacology. He currently serves on the FDA advisory committee for Clinical Pharmacology. Lastly, he maintains a clinical practice in vascular medicine and the treatment of complex venous and arterial thrombotic diseases.